Aptose Biosciences
APTO
#10585
Rank
A$6.09 M
Marketcap
A$2.39
Share price
0.00%
Change (1 day)
-48.90%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -A$31.68 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$35.23 Million, an increase over its 2023 earnings that were of -A$73.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$31.68 Million-10.09%
2024 -A$35.23 Million-51.82%
2023 -A$73.13 Million22.9%
2022 -A$59.51 Million-34.91%
2021 -A$91.42 Million17.36%
2020 -A$77.9 Million107.65%
2019 -A$37.52 Million-7.73%
2018 -A$40.66 Million160.68%
2017 -A$15.6 Million-20.27%
2016 -A$19.57 Million28.71%
2015 -A$15.2 Million
2013 -A$8.62 Million
2010 -A$7.34 Million-8.31%
2009 -A$8.01 Million
2006 -A$14.84 Million-156.93%
2005 A$26.06 M-185.16%
2004 -A$30.61 Million458.58%
2003 -A$5.48 Million-63.66%
2002 -A$15.08 Million-8.04%
2001 -A$16.4 Million16.73%
2000 -A$14.05 Million294.99%
1999 -A$3.56 Million-6.51%
1998 -A$3.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-A$87.69 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-A$94.3 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-A$47.53 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA